Drug companies are built in labs, not boardrooms
The history of ICI and the British pharmaceutical industry may provide some pointers to show how shareholders and policymakers should react to Pfizer’s bid for Astra Zeneca.
Drug companies are built in labs, not boardrooms Read More »
